INNOVIMMUNE is a specialty Drug Discovery & Exploratory Development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule NME immunomodulatory drugs for the treatment of Autoimmune, Inflammatory and Oncologic Diseases.
Follow us on Twitter: @Innovimmune
Company Details
- Founded
- -
- Address
- Innovimmune Biotherapeutics, New York,ny 10038,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.innovimmune.com
- Keywords
- Autoimmune Diseases, Preclinical Development, Nuclear Hormone Receptor, Retinoic Acid Receptor-Related Orphan Receptor [ROR], Macrophage Migration Inhibitory Factor [MIF], Nuclear Hormone Receptor [NHR], ImmunoOncology, Oncology, ROR gamma, ROR gamma agonist, ROR gamma inverse agonist, LXR agonist, FXR agonist, NLRP3 inflammasome inhibitor.
- HQ
- New York, NY
Innovimmune Biotherapeutics Questions
Innovimmune Biotherapeutics's website is http://www.innovimmune.com
Innovimmune Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/innovimmune
Innovimmune Biotherapeutics's industry is
Biotechnology Research
Innovimmune Biotherapeutics's top competitors are
Isabl,
Voltxon Inc,
Adita Bio Sys Private Limited,
Genotwin Inc.,
Maidstone Life Sciences,
Intersect Diagnostics,
Rover Diagnostics,
Valtedseq,
Uconn Technology Commercialization Services,
Tandem Labs.
Innovimmune Biotherapeutics's categories are Biotechnology Research
Innovimmune Biotherapeutics's founding year is 2010
